blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1978802

EP1978802 - POLYMERIZED HEMOGLOBIN MEDIA AND ITS USE IN ISOLATION AND TRANSPLANTATION OF ISLET CELLS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  22.01.2010
Database last updated on 14.09.2024
Most recent event   Tooltip22.01.2010Application deemed to be withdrawnpublished on 24.02.2010  [2010/08]
Applicant(s)For all designated states
NORTHFIELD LABORATORIES, INC.
Suite 1000, 1560 Sherman
Evanston, IL 60201-4422 / US
[2008/42]
Inventor(s)01 / DOUBLEDAY, Marc
326 Alicia Drive
Cary, IL 60013 / US
 [2008/42]
Representative(s)Smaggasgale, Gillian Helen
WP Thompson
138 Fetter Lane
London EC4A 1BT / GB
[N/P]
Former [2008/42]Smaggasgale, Gillian Helen
W.P. Thompson & Co, 55 Drury Lane
London WC2B 5SQ / GB
Application number, filing date07762535.824.01.2007
[2008/42]
WO2007US60989
Priority number, dateUS20060761663P24.01.2006         Original published format: US 761663 P
[2008/42]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2007087570
Date:02.08.2007
Language:EN
[2007/31]
Type: A2 Application without search report 
No.:EP1978802
Date:15.10.2008
Language:EN
The application published by WIPO in one of the EPO official languages on 02.08.2007 takes the place of the publication of the European patent application.
[2008/42]
Search report(s)International search report - published on:EP06.12.2007
ClassificationIPC:A01N1/02, A61K38/48, A61K38/42
[2008/42]
CPC:
A01N1/02 (EP,US); C12N5/0676 (US); A01N1/0226 (US);
A61K35/39 (EP,US); A61K38/42 (EP,US); A61K38/482 (EP,US);
A61K38/4886 (EP,US); A61P3/10 (EP) (-)
C-Set:
A61K35/39, A61K2300/00 (EP,US);
A61K38/42, A61K2300/00 (US,EP);
A61K38/482, A61K2300/00 (US,EP);
A61K38/4886, A61K2300/00 (US,EP)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2008/42]
Extension statesAL25.07.2008
BA25.07.2008
HR25.07.2008
MK25.07.2008
RS25.07.2008
TitleGerman:POLYMERISIERTES HÄMOGLOBINMEDIUM UND VERWENDUNG DAVON BEI DER ISOLIERUNG UND TRANSPLANTATION VON INSELZELLEN[2008/42]
English:POLYMERIZED HEMOGLOBIN MEDIA AND ITS USE IN ISOLATION AND TRANSPLANTATION OF ISLET CELLS[2008/42]
French:MILIEU D HEMOGLOBINE POLYMERISEE ET SON UTILISATION POUR L I̋SOLATION ET LA TRANSPLANTATION D I̋LOTS DE LANGERHANS[2008/42]
Entry into regional phase25.07.2008National basic fee paid 
25.07.2008Designation fee(s) paid 
25.07.2008Examination fee paid 
Examination procedure25.07.2008Examination requested  [2008/42]
14.10.2008Amendment by applicant (claims and/or description)
25.02.2009Despatch of a communication from the examining division (Time limit: M06)
08.09.2009Application deemed to be withdrawn, date of legal effect  [2010/08]
12.10.2009Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2010/08]
Fees paidRenewal fee
30.01.2009Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[Y]WO02089571  (BREONICS INC [US], et al) [Y] 1-34 * paragraph [0041]; claim - *;
 [DY]US6498141  (DEWOSKIN RICHARD E [US], et al) [DY] 1-34 * claim - *;
 [DY]US6506599  (YOON TAI-WOOK [KR]) [DY] 1-34 * claim - *;
 [Y]  - STANDL T, "Artificial oxygen carriers: Hemoglobin-based oxygen carriers - Current status 2004", TRANSFUSION MEDICINE AND HEMOTHERAPY, (2004), vol. 31, no. 4, ISSN 1660-3796, pages 262 - 268, XP009087719 [Y] 1-34 * the whole document *

DOI:   http://dx.doi.org/10.1159/000080412
 [Y]  - TOUSSAINT MARIE ET AL, "Effects of three Hb-based oxygen-carrying solutions on neutrophil activation in vitro: Quantitative measurement of the expression of adherence receptors", TRANSFUSION (BETHESDA), (200102), vol. 41, no. 2, ISSN 0041-1132, pages 226 - 231, XP002445628 [Y] 1-34 * page 227, column 1, paragraph 3 - page 228, column 1, paragraph 7 *
 [PX]  - AVILA J G ET AL, "Improved outcomes in islet isolation and transplantation by the use of a novel hemoglobin-based O2 carrier", AMERICAN JOURNAL OF TRANSPLANTATION 2006 UNITED KINGDOM, (2006), vol. 6, no. 12, ISSN 1600-6135 1600-6143, pages 2861 - 2870, XP002445629 [PX] 1-34 * the whole document *
 [X]  - WONG HIN-CHUNG ET AL, "Identification and characterization of a protease produced by Vibrio parahaemolyticus in iron-limited medium", BIOSIS, BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US, (1994), Database accession no. PREV199698749567, XP002445634 [X] 1,2,4,5,7-13,17,18,21,23-25,27-29 * abstract *
    [ ] - CHINESE JOURNAL OF MICROBIOLOGY AND IMMUNOLOGY (TAIPEI), (1994), vol. 27, no. 4, ISSN 0253-2662, pages 173 - 185
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.